Citation:Fairchild A, Harris K, Barnes E, Wong R, Lutz S, Bezjak A, et al 2008

From Cancer Guidelines Wiki

Citation


Fairchild A, Harris K, Barnes E, Wong R, Lutz S, Bezjak A, et al. Palliative thoracic radiotherapy for lung cancer: a systematic review. J Clin Oncol 2008 Aug 20;26(24):4001-11 Available from: http://www.ncbi.nlm.nih.gov/pubmed/18711191.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the optimal treatment approach for patients with stage III inoperable NSCLC who, because of patient or tumour factors, are not suitable for curative treatment with concurrent chemo-radiotherapy and who do not have a mutation for targeted therapy?Dr Margot Lehman MBBS FRANZCR GDPcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the optimal treatment approach for patients with stage III inoperable NSCLC who, because of patient or tumour factors, are not suitable for curative treatment with concurrent chemo-radiotherapy?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal treatment approach for patients with stage III inoperable NSCLC who, because of patient or tumour factors, are not suitable for curative treatment with concurrent chemo-radiotherapy?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the optimal treatment approach for patients with stage III inoperable NSCLC who, because of patient or tumour factors, are not suitable for curative treatment with concurrent chemo-radiotherapy and who do not have a mutation for targeted therapy?